| ARVO Home | Web Version | Mobile Version | Print-Friendly Version | Send to a Friend |
October 30, 2015

Deadline is today, Friday, Oct. 30 
Apply for $100K Epstein Award for glaucoma research
The David L. Epstein Award is a new annual award presented by the ARVO Foundation to a well-established, senior-level investigator with documented history of conducting eye and vision research in glaucoma.  

Apply today.

YO ARVO! Exploring Careers in Research
AAO Annual Meeting
Sunday, Nov. 15, 2:30pm 
YO Lounge, Room 102

The new interactive panel format offers young scientists and ophthalmologists the chance to direct pressing career questions to an influential group of ARVO clinician-scientists.
See who's speaking.

Submit your OCT paper
IOVS is accepting submissions for a special issue on Optical Coherence Tomography, with guest editors James Fujimoto, PhD, and David Huang, MD, PhD. The submission deadline is Dec. 14. Learn more.

Washington, D.C.-based federal employees: Donate through CFC Campaign (#38547) through Dec. 15. You can support the careers of vision researchers through payroll deductions — even a small amount per paycheck can make a difference. Learn more.



Manage ARVO e-News
Search Back Issues

Members in the news
Miller elected to the National Academy of Medicine

Joan W. Miller, MD, FARVO, received one of the highest honors in medicine for her contributions to ophthalmic medicine and vision science.

Community news
New policy mandates balance of the sexes in NIH research
Janine Austin Clayton, MD, NIH associate director for research on women’s health, offers insight into the new policy in "Changing the way scientists think about gender," an article in the latest ARVONews,
DoD to fund $20 million in vision research grants

Apply for grants funded by the Department of Defense 2015 and 2016 Vision Research Program.
Letter of intent deadline: Dec. 2.

Everything ARVO
Share in ARVOConnect and earn a Fellows point

Plus you can now protect your privacy and post anonymously in the Open Forum and Scientific Section communities.

Events and education
View session on clinical trials in diabetic retinopathy
Robert N. Frank, MD, FARVO, shares lessons from clinical trials and ideas for future direction in his recorded lecture from the recent ARVO Conference: Diabetic Retinopathy — Battling the Global Epidemic.
Who's meeting in the coming months?

Check out the ARVO Vision Community Calendar for a list of meetings happening around the world.

Advocay & Outreach
Congress passes budget bill, averting shutdown and default

The Bipartisan Budget Act of 2015 calls for government programs to receive an additional $50 billion in 2016. 

ARVO members participate in poster session on Capitol Hill

Early career researchers shared their research with U.S. Congressional representatives as part of an educational effort sponsored by the Alliance for Eye and Vision Research.

ARVO Journals
IOVS Research Highlight spotlights keratitis paper

Also read the lastest JOV and TVST published articles.

Apply for endowed professorship in neuroscience

And find positions open in retinopathy, ocular physiology, ophthalmology pharmacology, ocular imaging and more.

Funding opportunities

ARVO Funding Guide is a searchable database with over 200 opportunities listed. 

Get more information on opportunities with upcoming deadlines: 

  • Deadline Nov. 1:  AAAS Science & Technology Policy Fellowship
  • ARVO/VSS Summer Research Fellowship
  • Research to Prevent Blindness low vision awards
  • Knights Templar Eye Foundation Pediatric Ophthalmology Career-Starter Research Grants
  • Call for Nominations: $40,000 Roger H. Johnson Award
    Deadline: Oct. 31
Association for Research in Vision and Ophthalmology
1801 Rockville Pike, Suite 400 | Rockville MD 20852-5622
tel: + | fax: + | arvo@arvo.org | www.arvo.org
You are receiving ARVO Insight as a member service or because of your involvement with ARVO.
If you do not wish to receive Insight, please unsubscribe.

View ARVO's Privacy Policy.

To ensure delivery of Insight, please add arvo@arvo.org to your e-mail address book or Safe Sender List.
If you are still having problems receiving our communications, get more information about white-listing.